42nd Annual JP Morgan Healthcare Conference
Proven track record of beating the market
Zoetis has consistently grown faster than the core animal health market
7%
4%
7%
2013
6%
8%
5%
8%
7%
8%
2016
4%
8%
1
5%
8%
2018
2%
8%
2019
2014
2015
2017
2020
2021
Zoetis organic operational revenue growth
Industry operational revenue growth
8% Revenue CAGR since our IPO in 2013 compared to 5% for the Animal Health Industry³
1 Organic operational growth (a non-GAAP financial measure) excludes the impact of foreign exchange, the impact of acquisitions and the operational efficiency initiative in 2016. Reconciliations
of non-GAAP financial measures are available in the appendix to this presentation.
² Source: Vetnosis for historical core animal health market, including Zoetis from 2013 to 2022, excludes diagnostics, genetic tests, biodevices and precision animal health. Operational growth (a
non-GAAP financial measure) excludes the impact of foreign exchange.
3 Source: Vetnosis' estimated average annual growth rates from 2013 to 2022 in the core animal health market for Zoetis (-8%) as compared to estimates for the overall industry including Zoetis
(~5%). Operational growth (a non-GAAP financial measure) excludes the impact of foreign exchange.
6%
15%
10%
8%
2
3%
2022
zoetisView entire presentation